Pre-treatment with a Xingnaojing preparation ameliorates sevoflurane-induced neuroapoptosis in the infant rat striatum

Yang,Zhou‑Jing; Wang,Ying‑Wei; Li,Chang‑Lin; Ma,Li‑Qing; Zhao,Xuan

doi:10.3892/mmr.2014.2934

Pre-treatment with a Xingnaojing preparation ameliorates sevoflurane-induced neuroapoptosis in the infant rat striatum

Authors:
- Zhou‑Jing Yang
- Ying‑Wei Wang
- Chang‑Lin Li
- Li‑Qing Ma
- Xuan Zhao
View Affiliations

Affiliations: Department of Anesthesiology and Intensive Care Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200092, P.R. China
Published online on: November 13, 2014 https://doi.org/10.3892/mmr.2014.2934
Pages: 1615-1622
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Xingnaojing (XNJ), is a standardized Chinese herbal medicine product derived from An Gong Niu Huang Pill. It may be involved in neuroprotection in a number of neurological disorders. Exposure to anesthetic agents during the brain growth spurt may trigger widespread neuroapoptosis in the developing brain. Thus the present study aimed to identify whether there was a neuroprotective effect of XNJ on anesthesia‑induced neuroapoptosis. Seven‑day‑old rats received treatment with 2.1% sevoflurane for 6 h. Rat pups were injected intraperitoneally with 1 or 10 ml/kg XNJ at 0.2, 24 and 48 h prior to sevoflurane exposure. The striata of neonatal rats were collected following administration of anesthesia. Western blotting and immunohistochemistry were used to analyze the expression of activated caspase 3, Bax and phosphorylated protein kinase B (p‑AKT) in the striatum. It was found that activated caspase 3 and Bax expression were upregulated in the striatum following sevoflurane treatment. Preconditioning with XNJ attenuated the neuronal apoptosis induced by sevoflurane in a dose‑dependent manner. Anesthesia reduced the expression of p‑AKT (phosphorylated at sites Thr308 and Ser473) and phosphorylated extracellular‑regulated protein kinase (p‑ERK) in the striatum. Pre‑treatment with XNJ reversed the reduction in p‑AKT, but not p‑ERK expression. These data suggest that XNJ has an antiapoptotic effect against sevoflurane‑induced cell loss in the striatum. It thus holds promise as a safe and effective neuroprotective agent. The action of XNJ on p‑AKT may make a significant contribution to its neuroprotective effect.

View Figures

View References

1	Lerman J, Sikich N, Kleinman S and Yentis S: The pharmacology of sevoflurane in infants and children. Anesthesiology. 80:814–824. 1994. View Article : Google Scholar : PubMed/NCBI
2	Satomoto M, Satoh Y, Terui K, et al: Neonatal exposure to sevoflurane induces abnormal social behaviors and deficits in fear conditioning in mice. Anesthesiology. 110:628–637. 2009. View Article : Google Scholar : PubMed/NCBI
3	Dikranian K, Ishimaru MJ, Tenkova T, et al: Apoptosis in the in vivo mammalian forebrain. Neurobiol Dis. 8:359–379. 2001. View Article : Google Scholar : PubMed/NCBI
4	Dikranian K, Qin YQ, Labruyere J, Nemmers B and Olney JW: Ethanol-induced neuroapoptosis in the developing rodent cerebellum and related brain stem structures. Brain Res Dev Brain Res. 155:1–13. 2005. View Article : Google Scholar : PubMed/NCBI
5	Olney JW, Tenkova T, Dikranian K, Qin YQ, Labruyere J and Ikonomidou C: Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res Dev Brain Res. 133:115–126. 2002. View Article : Google Scholar : PubMed/NCBI
6	Olney JW, Tenkova T, Dikranian K, et al: Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol Dis. 9:205–219. 2002. View Article : Google Scholar : PubMed/NCBI
7	Young C, Klocke BJ, Tenkova T, et al: Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain. Cell Death Differ. 10:1148–1155. 2003. View Article : Google Scholar : PubMed/NCBI
8	Young C, Roth KA, Klocke BJ, et al: Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiol Dis. 20:608–614. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lv L, Liu Y, Shi HF and Dong Q: Qingkailing injection attenuates apoptosis and neurologic deficits in a rat model of intracerebral hemorrhage. J Ethnopharmacol. 125:269–273. 2009. View Article : Google Scholar : PubMed/NCBI
10	Xu P, Du SY, Lu Y, et al: The effect of stroke and other components in Xing-Nao-Jing on the pharmacokinetics of geniposide. J Ethnopharmacol. 152:302–307. 2014. View Article : Google Scholar : PubMed/NCBI
11	Wei G, Chen DF, Lai XP, et al: Muscone exerts neuroprotection in an experimental model of stroke via inhibition of the fas pathway. Nat Prod Commun. 7:1069–1074. 2012.PubMed/NCBI
12	Yang XL, Xu WY, G YX, LYP and Sun Y: Studies on pharmacological action of Xingnaojing injection. China Pharmacy. 22–23. 1993.(In Chinese).
13	Ministry of Public Health. Drug Standard of Ministry of Public Health of the Peoples Republic of China. People’s Medical Publishing House; Beijing: 1998
14	Zhang QD, Liu DH, Lin WW, Wei G, Huang YC and Feng XQ: Analysis of Xingnaojing injection by chiral capillary gas chromatography. Traditional Chinese Drug Research & Clinical Pharmacology. 23:338–341. 2012.(In Chinese).
15	Wang LQ, Wang SL and SU DS: Quality control study of Xingnaojing injection. Chinese Traditional Patent Medicine. 26:289–291. 2004.(In Chinese).
16	Yang LX, Liu WW, Gan GF, Zhou FK, He XR and Li C: Simultaneous determination of curdione and germacrone in Xingnaojing injection using high performance liquid chromatography. Chinese Journal of Experimental Traditional Medical Formulae. 17:136–139. 2013.(In Chinese).
17	Xu M, Su W, Xu QP and Huang WD: Effect of Xingnaojing injection on cerebral edema and blood-brain barrier in rats following traumatic brain injury. Chinese J Traumatol. 13:158–162. 2010.
18	Rupinder SK, Gurpreet AK and Manjeet S: Cell suicide and caspases. Vascular Pharmacol. 46:383–393. 2007. View Article : Google Scholar
19	Reed JC: Bcl-2 family proteins. Oncogene. 17:3225–3236. 1998. View Article : Google Scholar
20	Straiko MM, Young C, Cattano D, et al: Lithium protects against anesthesia-induced developmental neuroapoptosis. Anesthesiology. 110:862–868. 2009. View Article : Google Scholar : PubMed/NCBI
21	Edwards DA, Shah HP, Cao W, Gravenstein N, Seubert CN and Martynyuk AE: Bumetanide alleviates epileptogenic and neurotoxic effects of sevoflurane in neonatal rat brain. Anesthesiology. 112:567–575. 2010. View Article : Google Scholar : PubMed/NCBI
22	Takaenoki Y, Satoh Y, Araki Y, et al: Neonatal exposure to sevoflurane in mice causes deficits in maternal behavior later in adulthood. Anesthesiology. 120:403–415. 2014. View Article : Google Scholar
23	Zheng SQ, An LX, Cheng X and Wang YJ: Sevoflurane causes neuronal apoptosis and adaptability changes of neonatal rats. Acta Anaesthesiol Scand. 57:1167–1174. 2013. View Article : Google Scholar : PubMed/NCBI
24	Furuyashiki T and Deguchi Y: Roles of altered striatal function in major depression. Brain Nerve. 64:919–926. 2012.(In Japanese). PubMed/NCBI
25	Liljeholm M and O’Doherty JP: Contributions of the striatum to learning, motivation, and performance: an associative account. Trends Cogn Sci. 16:467–475. 2012. View Article : Google Scholar : PubMed/NCBI
26	Scimeca JM and Badre D: Striatal contributions to declarative memory retrieval. Neuron. 75:380–392. 2012. View Article : Google Scholar : PubMed/NCBI
27	Su WD, Huang YD, Qu EL, Zhang Y, Ye W and Bao M: Effect of angong niuhuang pill as an adjuvant treatment on moderate or severe neonatal hypoxic-ischemic Encephalopathy. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:652–654. 2005.(In Chinese). PubMed/NCBI
28	Chen WK, Huang YF and Wang HD: An experimental study on distribution of musk into the brain through blood brain barrier. Zhong Xi Yi Jie He Xue Bao. 2:288–291. 2004. View Article : Google Scholar : PubMed/NCBI
29	Zhao JY, Lu Y, Du SY, Song X, Bai J and Wang Y: Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations. J Zhejiang Univ Sci B. 13:990–996. 2012. View Article : Google Scholar : PubMed/NCBI
30	Lu Y, Du S, Bai J, Li P, Wen R and Zhao X: Bioavailability and brain-targeting of geniposide in gardenia-borneol co-compound by different administration routes in mice. Int J Mol Sci. 13:14127–14135. 2012. View Article : Google Scholar : PubMed/NCBI
31	Liang MR, Liu QD, Huang TL, Zhang YQ and Ou WP: The pharmacokinetic characteristics of borneol in serum and brain tissue of rats. Traditional Chinese Drug Research & Clinical Pharmacology. 38–40. 621993.(In Chinese).
32	Tao W, Xu X, Wang X, et al: Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 145:1–10. 2013. View Article : Google Scholar
33	Bai J, Zeng Q and Chai Z: Clinical and experimental study on treatment of acute alcohol intoxication with xiangnaojing injection. Zhongguo Zhong Xi Yi Jie He Za Zhi. 18:607–609. 1998.(In Chinese).
34	Guo F, Lu XW and Xu QP: Protective effect of Xingnaojing and Xuesaitong injections on cerebral ischemic reperfusion injury in rats. Zhonghua Yi Xue Za Zhi. 90:1645–1647. 2010.PubMed/NCBI
35	Wang LC and Liu HY: Clinical observation on acupuncture combined with Xingnaojing injection for treatment of cerebral hemorrhage at acute stage. Zhongguo Zhen Jiu. 26:253–255. 2006.(In Chinese). PubMed/NCBI
36	Wen HM, Lin SY, Gao J, et al: Protective effect and mechanism of Xingnaojing injection on ketamine-induced impairment of learning and memory. Guangdong Medical Journal. 33:1546–1549. 2012.(In Chinese).
37	Li GC and Mai SD: Effects of Fufang Shexiang injection on dysfunction of learning and memory post-anesthesia with ketamine in aged rats. China Healthcare Innovation. 3:12–13. 2008.(In Chinese).
38	Wang WY, Yang R, Hu SF, Wang H, Ma ZW and Lu Y: N-stearoyl-L-tyrosine ameliorates sevoflurane induced neuroapoptosis via MEK/ERK1/2 MAPK signaling pathway in the developing brain. Neurosci Lett. 541:167–172. 2013. View Article : Google Scholar : PubMed/NCBI
39	Yuan J and Yankner BA: Apoptosis in the nervous system. Nature. 407:802–809. 2000. View Article : Google Scholar : PubMed/NCBI
40	Kuribayashi K, Mayes PA and El-Deiry WS: What are caspases 3 and 7 doing upstream of the mitochondria? Cancer Biol Ther. 5:763–765. 2006. View Article : Google Scholar : PubMed/NCBI
41	Dohare P, Garg P, Sharma U, Jagannathan NR and Ray M: Neuroprotective efficacy and therapeutic window of curcuma oil: in rat embolic stroke model. BMC Complement Altern Med. 8:552008. View Article : Google Scholar : PubMed/NCBI
42	Dummler B and Hemmings BA: Physiological roles of PKB/Akt isoforms in development and disease. Biochem Soc Trans. 35:231–235. 2007. View Article : Google Scholar : PubMed/NCBI
43	Cantley LC: The phosphoinositide 3-kinase pathway. Science. 296:1655–1657. 2002. View Article : Google Scholar : PubMed/NCBI
44	Cardone MH, Roy N, Stennicke HR, et al: Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1318–1321. 1998. View Article : Google Scholar : PubMed/NCBI
45	Manning BD and Cantley LC: AKT/PKB signaling: navigating downstream. Cell. 129:1261–1274. 2007. View Article : Google Scholar : PubMed/NCBI
46	Dudek H, Datta SR, Franke TF, et al: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:661–665. 1997. View Article : Google Scholar : PubMed/NCBI
47	Marushige K and Marushige Y: Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis. Anticancer Res. 19:3865–3871. 1999.
48	Xin M and Deng X: Nicotine inactivation of the proapoptotic function of Bax through phosphorylation. J Biol Chem. 280:10781–10789. 2005. View Article : Google Scholar : PubMed/NCBI
49	Ishrat T, Sayeed I, Atif F, Hua F and Stein DG: Progesterone is neuroprotective against ischemic brain injury through its effects on the phosphoinositide 3-kinase/protein kinase B signaling pathway. Neuroscience. 210:442–450. 2012. View Article : Google Scholar : PubMed/NCBI
50	Ullah N, Ullah I, Lee HY, et al: Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain. J Mol Neurosci. 47:67–75. 2012. View Article : Google Scholar